Updated:
Zhaoyin Equity Investment Fund Management
Zhaoyin Equity Investment Fund Management was established in 2012 as the direct-investment arm of China Merchants Bank (CMB), the Shenzhen-headquartered...
Zhaoyin Equity Investment Fund Management
Zhaoyin Equity Investment Fund Management was established in 2012 as the direct-investment arm of China Merchants Bank (CMB), the Shenzhen-headquartered joint-stock commercial bank whose private banking division is among the largest in China by assets under management. Zhaoyin operates from Shanghai under a fund-management license, raising renminbi-denominated vehicles primarily from CMB's private wealth clients, institutional limited partners, and government guidance funds. Its formation reflected a broader wave of Chinese financial institutions spinning out dedicated alternatives platforms to capture the equity upside their balance sheets could not pursue directly. The firm invests across the full lifecycle of private companies — seed, start-up, venture, growth, and pre-IPO — with a disclosed focus on healthcare services, enterprise software, industrial technology, and consumer sectors. Zhaoyin also executes private investment in public equity transactions. Portfolio exposure extends across Greater China, with particular concentration in the Yangtze River Delta and Pearl River Delta manufacturing corridors. Representative investments have included medical-device companies, industrial-automation suppliers, and software platforms serving China's digitizing small and medium enterprise sector, though the firm does not publish a full portfolio list. Zhaoyin has scaled significantly since its first fund, benefiting from CMB's distribution engine, which channels high-net-worth allocations into in-house products. The firm manages multiple vintages and counts among the larger bank-affiliated private equity managers in Shanghai. The leadership team draws from CMB's investment banking and wealth management ranks, though the firm does not separately disclose detailed biographies or headcount figures. No specific philanthropic foundation or adjacent operating business is publicly associated with the Zhaoyin platform. A structural differentiator for Zhaoyin is its embedded distribution: unlike independent private equity managers that must court third-party wealth channels, Zhaoyin's limited partner base is substantially pre-assembled through China Merchants Bank's retail and private-banking network. This captive fundraising capability allows the firm to close renminbi funds on accelerated timelines and places it among a select group of bank-affiliated alternatives managers — including CICC Capital and CITIC Private Equity — that blend banking origination with direct-equity investing.
General information
Firm type
Private Equity
Year founded
2012
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Sector focus
Frequently asked questions
Who owns Zhaoyin Equity Investment Fund Management?
Zhaoyin is a subsidiary of China Merchants Bank (CMB), one of China's largest joint-stock commercial banks. CMB established the platform in 2012 to manage direct private equity investments on behalf of the bank and its private wealth clients. The ownership structure places Zhaoyin within a regulated financial holding group, giving it a different risk and compliance posture than an independent general partner.
How does the firm source its investment opportunities?
Zhaoyin sources deals through multiple channels specific to its banking parent. China Merchants Bank's corporate banking relationships across manufacturing, healthcare, and technology sectors generate a proprietary pipeline of private companies seeking growth capital. The firm also benefits from CMB's private banking network, where entrepreneur-clients often present investment opportunities before they reach the broader market.
Does Zhaoyin invest in renminbi or US dollar funds?
Zhaoyin primarily manages renminbi-denominated funds raised from domestic Chinese limited partners, including CMB's private wealth clients and provincial government guidance funds. There is no public record of the firm operating a US dollar-denominated vehicle or actively soliciting foreign institutional capital.
What is Zhaoyin's relationship to China Merchants Bank's wealth management business?
Zhaoyin functions as a key product manufacturer for CMB's private banking and wealth management distribution platform. CMB's relationship managers offer Zhaoyin-managed private equity funds to qualified high-net-worth clients, providing the firm with a fundraising channel that independent Chinese private equity managers typically cannot replicate without paying placement agent fees.
How does Zhaoyin's structure compare to other bank-affiliated private equity firms in China?
Zhaoyin sits within a peer group that includes CICC Capital (affiliated with China International Capital Corporation), CITIC Private Equity (affiliated with CITIC Group), and CCB International's private equity operations. Each of these platforms uses a major financial institution's balance sheet, corporate relationships, and wealth distribution network to originate, fund, and exit private equity investments — a model that differs fundamentally from independent partnerships like Hillhouse Capital or Boyu Capital.
What stages of investment does Zhaoyin target?
The firm's mandate covers early-stage venture, growth equity, and pre-IPO rounds, along with private investment in public equity transactions. This broad mandate reflects the bank's desire to capture returns across the full maturity curve of Chinese private companies, from start-ups emerging out of industrial clusters to established enterprises preparing for domestic A-share listings.
Where does Zhaoyin concentrate its investments geographically?
Zhaoyin concentrates its deal activity in Greater China, with a heavy emphasis on Shanghai and the surrounding Yangtze River Delta region, as well as the Pearl River Delta anchored by Shenzhen — the headquarters of its parent, China Merchants Bank. These two corridors house the bulk of China's private manufacturing, healthcare, and technology companies that fit Zhaoyin's sector focus.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: